MarcJosephGurwithMD

PubMed

• A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Novavax COVID-19 Vaccine (NVX-CoV2373), a recombinant spik...
  Bethanie Wilkinson, Kinjal S Patel, Katherine Smith, Robert Walker, Chengbin Wang, Ann M Greene, Gale Smith, Emily R Smith, Marc Gurwith, Robert T Chen> ;Vaccine. 2023 Oct 26
• 3 citations
  A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine.
  Lila Estephan, Luke Tzu-Chi Liu, Chia En Lien, Emily R Smith, Marc Gurwith, Robert T Chen> ;Vaccine. 2023 Apr 6
• 2 citations
  A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Moderna COVID-19 Vaccine (mRNA-1273).
  Brett Leav, Walter Straus, Phil White, Alison Leav, Tashawnee Gaines, Grace Maggiacomo, Denny Kim, Emily R Smith, Marc Gurwith, Robert T Chen> ;Vaccine. 2022 Aug 19
• 7 citations
  Vaccines based on the replication-deficient simian adenoviral vector ChAdOx1: Standardized template with key considerations for a risk/benefit assessment.
  Pedro M Folegatti, Daniel Jenkin, Susan Morris, Sarah Gilbert, Denny Kim, James S Robertson, Emily R Smith, Emalee Martin, Marc Gurwith, Robert T Chen> ;Vaccine. 2022 Aug 19
• 2 citations
  A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for an inactivated viral vaccine against Chikungunya virus.
  Libia Milena Hernandez, K Sumathy, Sushant Sahastrabuddhe, Jean-Louis Excler, Sonali Kochhar, Emily R Smith, Marc Gurwith, Robert T Chen> ;Vaccine. 2022 Aug 19
• 3 citations
  A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Ni...
  John H. Eldridge, Michael A. Egan, Demetrius Matassov, Stefan Hamm, Luz Hermida, Tracy Chen, Marc Tremblay, Susan Sciotto-Brown, Rong Xu, Antony S. Dimitrov, Emily R. ...> ;Vaccine. 2021 Aug 7
• 43 citations
  Vaccines based on replication incompetent Ad26 viral vectors: standardized template with key considerations for a risk/benefit assessment
  Jerome Custers, Denny Kim, Maarten Leyssen, Marc Gurwith, Frank Tomaka, James S. Robertson, Esther Heijnen, Richard C. Condit, Georgi Shukarev, Dirk Heerwegh, Roy van ...> ;Vaccine. 2021 May 21
• 44 citations
  The critical role of background rates of possible adverse events in the assessment of COVID-19 vaccine safety.
  Steven Black, Barbara Law, Robert T. Chen, Cornelia L. Dekker, Miriam C. J. M. Sturkenboom, Wan-Ting Huang, Marc Gurwith, G.A. Poland> ;Vaccine. 2021 May 6
• 34 citations
  A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity
  Kenta Matsuda, Stephen A. Migueles, Jinghe Huang, Lyuba Bolkhovitinov, Sarah Stuccio, Trevor Griesman, Alyssa A. Pullano, Byong H. Kang, Elise Ishida, Matthew G. Zimme...> ;The Journal of Clinical Investigation. 2021 Mar 3
• 58 citations
  Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
  Flor M. Munoz, Jakob P. Cramer, Cornelia L. Dekker, Matthew Z. Dudley, Barney S. Graham, Marc Gurwith, Barbara Law, Stanley Perlman, Fernando P. Polack, Jonathan M. Sp...> ;Vaccine. 2021 Feb 23
• 1 citations
  The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of viral vector vaccines.
  Richard C Condit, Denny Kim, James S Robertson, Jean-Louis Excler, Marc Gurwith, Thomas P Monath, George Pavlakis, Patricia E Fast, Jonathan Smith, Emily R Smith, Robe...> ;Vaccine. 2020 Nov 17
• 5 citations
  Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-a...
  Marc Gurwith, Richard C. Condit, Jean-Louis Excler, James S. Robertson, Denny Kim, Patricia E. Fast, Stephen Drew, David Wood, Bettina Klug, Mike Whelan, Tamala Mallet...> ;Vaccine. 2020 Nov 17
• 1 citations
  The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines.
  Sonali Kochhar, Jean-Louis Excler, Denny Kim, James S Robertson, Patricia E Fast, Richard C Condit, Stephen Drew, David Wood, Marc Gurwith, Bettina Klug, Mike Whelan, ...> ;Vaccine. 2020 Sep 3
• 3 citations
  The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.
  Sonali Kochhar, Denny Kim, Jean-Louis Excler, Richard C Condit, James S Robertson, Stephen Drew, Mike Whelan, David Wood, Patricia E Fast, Marc Gurwith, Bettina Klug, ...> ;Vaccine. 2020 Jul 31
• 10 citations
  The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of nucleic acid (RNA and DNA) vaccines.
  Denny Kim, James S. Robertson, Jean-Louis Excler, Richard C. Condit, Patricia E. Fast, Marc Gurwith, George N. Pavlakis, Thomas P. Monath, Jonathan M. Smith, David Woo...> ;Vaccine. 2020 Jul 22
• 11 citations
  Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba
  Motaher Hossain, Kamrul Islam, Meagan Kelly, Leslie M. Mayo Smith, Richelle C. Charles, Ana A. Weil, Taufiqur Rahman Bhuiyan, Pavol Kováč, Peng Xu, Stephen B. Calderwo...> ;Plos Neglected Tropical Diseases. 2019 Nov 19
• 14 citations
  Defining the interval for monitoring potential adverse events following immunization (AEFIs) after receipt of live viral vectored vaccines.
  Sonali Kochhar, Jean-Louis Excler, Karin Bok, Marc Gurwith, Michael M. McNeil, Stephen J. Seligman, Najwa Khuri-Bulos, Bettina Klug, Marian P Laderoute, James S. Rober...> ;Vaccine. 2019 Sep 10
• 37 citations
  Prolonged evolution of the memory B cell response induced by a replicating adenovirus-influenza H5 vaccine
  Kenta Matsuda, Jinghe Huang, Tongqing Zhou, Zizhang Sheng, Byong H. Kang, Elise Ishida, Trevor Griesman, Sarah Stuccio, Lyuba Bolkhovitinov, Teddy John Wohlbold, Veron...> ;Science Immunology. 2019 Apr 19
• 11 citations
  Age-related immunogenicity and reactogenicity of live oral cholera vaccine CVD 103-HgR in a randomized, controlled clinical trial.
  James M. McCarty, Michael Lock, Sean Bennett, Kristin Hunt, Jakub K. Simon, Marc Gurwith> ;Vaccine. 2019 Mar 7
• 43 citations
  Estimating cholera incidence with cross-sectional serology
  Andrew S. Azman, Justin Lessler, Francisco J. Luquero, Taufiqur Rahman Bhuiyan, Ashraful Islam Khan, Fahima Chowdhury, Alamgir Kabir, Marc Gurwith, Ana A. Weil, Jason ...> ;Science Translational Medicine. 2019 Feb 20
• 20 citations
  Lipopolysaccharide-specific memory B cell responses to an attenuated live cholera vaccine are associated with protection against Vibrio cholerae infection.
  Douglas Haney, Michael Lock, Marc Gurwith, Jakub K. Simon, Glenn Ishioka, Mitchell B. Cohen, Beth D. Kirkpatrick, Caroline E. Lyon, Wilbur H. Chen, Marcelo B. Sztein, ...> ;Vaccine. 2018 May 11
• 24 citations
  Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infec...
  Kamrul Islam, Motaher Hossain, Meagan Kelly, Leslie M. Mayo Smith, Richelle C. Charles, Taufiqur Rahman Bhuiyan, Pavol Kováč, Peng Xu, Regina C. LaRocque, Stephen B. C...> ;Plos Neglected Tropical Diseases. 2018 Apr 6
• 14 citations
  Safety and immunogenicity of single-dose live oral cholera vaccine strain CVD 103-HgR in healthy adults age 18–45
  James M. McCarty, Michael Lock, Kristin Hunt, Jakub K. Simon, Marc Gurwith> ;Vaccine. 2018 Feb 1
• 39 citations
  Passive Transfer of Immune Sera Induced by a Zika Virus-Like Particle Vaccine Protects AG129 Mice Against Lethal Zika Virus Challenge.
  Diego A. Espinosa, Jason Mendy, Darly J. Manayani, Lo Vang, Chunling Wang, Tiffany Richard, Ben Guenther, Jayavani Aruri, Jenny B. Avanzini, Fermin Garduno, Peggy Farn...> ;Ebiomedicine. 2017 Dec 12
• 21 citations
  Combination Adenovirus and Protein Vaccines Prevent Infection or Reduce Viral Burden after Heterologous Clade C Simian-Human Immunodeficiency Virus Mucosal Challenge
  Delphine C. Malherbe, Jason Mendy, Lo Vang, Philip Barnette, Jason S. Reed, Samir K. Lakhashe, Joshua Owuor, Johannes S. Gach, Alfred W. Legasse, Michael K. Axthelm, C...> ;Journal of Virology. 2017 Nov 1
• Join now to see all